Abstract
Introduction
Ischemic stroke treatment has advanced in the last two decades and intravenous thrombolysis is now considered the standard of care for selected patients. Recanalization can also be achieved by mechanical endovascular treatment for patients with large vessel occlusions. Complicating treatment-related symptomatic intracerebral hemorrhage and prolonged needle-to-recanalization times have been identified as major determinants of poor three-month functional outcomes. A hybrid mechanical-thrombolytic system with a patch imbued with an ultra-low dose of thrombolytic agents loaded onto a stent-retriever has been developed.
Methods
In this study, the in situ dose–response relationship of the thrombolytic patch imbued with up to 1000 IU of urokinase plasminogen activator (uPA) was quantified using Raman spectroscopy.
Results
Thrombi of up to 400 μm thickness dissolved within 15 min when patches imbued with < 1% of the conventional thrombolysis therapy dosage were applied. The results demonstrated that low-dose thrombolytic patches can dissolve normal clots compressed in the blood vessel in a short time. 500 IU is the threshold uPA dosage in the thrombolytic patch that most effectively dissolves the clots.
Conclusion
This study suggests that a novel endovascular stent-retriever loaded with an ultra-low drug dose fibrinolytic patch may be a suitable treatment for patients who are ineligible for conventional thrombolytic therapy.
Similar content being viewed by others
References
Adeoye, O., R. Hornung, P. Khatri, and D. Kleindorfer. Recombinant tissue-type plasminogen activator use for ischemic stroke in the united states a doubling of treatment rates over the course of 5 years. Stroke 42:1952–1955, 2011.
Alexandrov, A. V., and J. C. Grotta. Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator. Neurology 59:862–867, 2002.
Ali, N. S., J. M. Akudugu, and R. W. Howell. A preliminary study on treatment of human breast cancer xenografts with a cocktail of paclitaxel, doxorubicin, and 131I-anti-epithelial cell adhesion molecule (9C4). World J. Nucl. Med. 18:18, 2019.
Anderson, C. S., T. Robinson, R. I. Lindley, H. Arima, P. M. Lavados, T.-H. Lee, J. P. Broderick, X. Chen, G. Chen, and V. K. Sharma. Low-dose versus standard-dose intravenous alteplase in acute ischemic stroke. N. Engl. J. Med. 374:2313–2323, 2016.
Andersson, T., M. Wiesmann, O. Nikoubashman, A. Gopinathan, P. Bhogal, and L. L. Yeo. The aspirations of direct aspiration for thrombectomy in ischemic stroke: a critical analysis. J. Stroke 21:2–9, 2019.
Balami, J., P. White, P. McMeekin, G. Ford, and A. Buchan. Complications of endovascular treatment for acute ischemic stroke. Int. J. Stroke 13(4):348–361, 2017.
Balami, J. S., G. Hadley, B. A. Sutherland, H. Karbalai, and A. M. Buchan. The exact science of stroke thrombolysis and the quiet art of patient selection. Brain 136:3528–3553, 2013.
Boyd, S., M. F. Bertino, D. Ye, L. S. White, and S. J. Seashols. Highly sensitive detection of blood by surface enhanced Raman scattering. J. Forensic Sci. 58:753–756, 2013.
Brunser, A. M., S. Illanes, P. M. Lavados, P. Muñoz, D. Cárcamo, A. Hoppe, V. V. Olavarria, I. Delgado, and V. Díaz. Exclusion criteria for intravenous thrombolysis in stroke mimics: an observational study. J. Stroke Cerebrovasc. Dis. 22:1140–1145, 2013.
Chang, K.-C., S.-W. Hsu, C.-W. Liou, Y.-C. Huang, L.-H. Lee, C.-C. Lui, and Y.-L. Kuo. Intra-arterial thrombolytic therapy for acute intracranial large artery occlusive disease in patients selected by magnetic resonance image. J. Neurol. Sci. 297:46–51, 2010.
Dargazanli, C., R. Fahed, R. Blanc, B. Gory, J. Labreuche, A. Duhamel, G. Marnat, S. Saleme, V. Costalat, and S. Bracard. Modified thrombolysis in cerebral infarction 2c/thrombolysis in cerebral infarction 3 reperfusion should be the aim of mechanical thrombectomy: insights from the ASTER Trial (Contact Aspiration Versus Stent Retriever for Successful Revascularization). Stroke 49:1189–1196, 2018.
Demaerschalk, B. M., D. O. Kleindorfer, O. M. Adeoye, A. M. Demchuk, J. E. Fugate, J. C. Grotta, A. A. Khalessi, E. I. Levy, Y. Y. Palesch, and S. Prabhakaran. Scientific rationale for the inclusion and exclusion criteria for intravenous alteplase in acute ischemic stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 47:581–641, 2016.
Diamond, S. L., and S. Anand. Inner clot diffusion and permeation during fibrinolysis. Biophys. J . 65:2622–2643, 1993.
Diedler, J., N. Ahmed, M. Sykora, M. Uyttenboogaart, K. Overgaard, G.-J. Luijckx, L. Soinne, G. A. Ford, K. R. Lees, and N. Wahlgren. Safety of intravenous thrombolysis for acute ischemic stroke in patients receiving antiplatelet therapy at stroke onset. Stroke 41:288–294, 2010.
Dirks, M., L. W. Niessen, P. J. Koudstaal, C. L. Franke, R. J. van Oostenbrugge, and D. W. Dippel. Intravenous thrombolysis in acute ischaemic stroke: from trial exclusion criteria to clinical contraindications. An international Delphi study. J. Neurol. Neurosurg. Psychiatry 78:685–689, 2007.
Fransen, P. S., D. Beumer, O. A. Berkhemer, L. A. van den Berg, H. Lingsma, A. van der Lugt, W. H. van Zwam, R. J. van Oostenbrugge, Y. B. Roos, and C. B. Majoie. MR CLEAN, a multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke in the Netherlands: study protocol for a randomized controlled trial. Trials 15:1, 2014.
Gariel, F., B. Lapergue, R. Bourcier, J. Berge, X. Barreau, M. Mazighi, M. Kyheng, J. Labreuche, R. Fahed, and R. Blanc. Mechanical thrombectomy outcomes with or without intravenous thrombolysis: insight from the ASTER randomized trial. Stroke 49:2383–2390, 2018.
Gory, B., B. Lapergue, R. Blanc, J. Labreuche, M. Ben Machaa, A. Duhamel, G. Marnat, S. Saleme, V. Costalat, and S. Bracard. Contact aspiration versus stent retriever in patients with acute ischemic stroke with M2 occlusion in the ASTER randomized trial (contact aspiration versus stent retriever for successful revascularization). Stroke 49:461–464, 2018.
Hacke, W., P. Lyden, J. Emberson, C. Baigent, L. Blackwell, G. Albers, E. Bluhmki, T. Brott, G. Cohen, and S. M. Davis. Effects of alteplase for acute stroke according to criteria defining the European Union and United States marketing authorizations: individual-patient-data meta-analysis of randomized trials. Int. J. Stroke 13:175–189, 2018.
Jain, R., D. Calderon, P. R. Kierski, M. J. Schurr, C. J. Czuprynski, C. J. Murphy, J. F. McAnulty, and N. L. Abbott. Raman spectroscopy enables noninvasive biochemical characterization and identification of the stage of healing of a wound. Anal. Chem. 86:3764–3772, 2014.
Jansen, I. G., M. J. Mulder, and R.-J. B. Goldhoorn. Endovascular treatment for acute ischaemic stroke in routine clinical practice: prospective, observational cohort study (MR CLEAN Registry). bmj 360:k949, 2018.
Janssen, H., H. Brückmann, M. Killer, S. Heck, G. Buchholz, and J. Lutz. Acute basilar thrombosis: Recanalization following intravenous thrombolysis is dependent on thrombus length. PLoS ONE 13:2018.
Kang, D.-H., Y.-H. Hwang, Y.-S. Kim, J. Park, O. Kwon, and C. Jung. Direct thrombus retrieval using the reperfusion catheter of the penumbra system: forced-suction thrombectomy in acute ischemic stroke. Am. J. Neuroradiol. 32:283–287, 2011.
Kuoppala, M., J. Åkeson, P. Svensson, B. Lindblad, S. Franzen, and S. Acosta. Risk factors for haemorrhage during local intra-arterial thrombolysis for lower limb ischaemia. J. Thromb. Thrombolysis 31:226–232, 2011.
Kwok, J. C. K., W. Huang, W.-C. Leung, S.-K. Chan, K.-Y. Chan, K.-M. Leung, A. C. H. Chu, and A. K. N. Lam. Human placenta as an ex vivo vascular model for neurointerventional research. J. Neurointervent. Surg. 6:394, 2013.
la Rosa F. d. l. R., J. Khoury, B. M. Kissela, M. L. Flaherty, K. Alwell, C. J. Moomaw, P. Khatri, O. Adeoye, D. Woo, and S. Ferioli. Eligibility for intravenous recombinant tissue-type plasminogen activator within a population. The Effect of the European Cooperative Acute Stroke Study (ECASS) III Trial. Stroke 43:1591–1595, 2012.
Lapergue, B., R. Blanc, B. Gory, J. Labreuche, A. Duhamel, G. Marnat, S. Saleme, V. Costalat, S. Bracard, and H. Desal. Effect of endovascular contact aspiration vs stent retriever on revascularization in patients with acute ischemic stroke and large vessel occlusion: the ASTER randomized clinical trial. JAMA 318:443–452, 2017.
Lefebvre, P., and I. Cohen. Effects of platelets and plasma on fibrinolysis. Blood Coag. Fibrinol. 3:237–242, 1992.
Levine S. R., E. C. Haley, and P. D. Lyden. Pilot and preliminary studies of thrombolytic therapy for stroke. In: Thrombolytic Therapy for Acute Stroke. Springer, 2015, pp. 81–94.
Levine, S. R., P. Khatri, J. P. Broderick, J. C. Grotta, S. E. Kasner, D. Kim, B. C. Meyer, P. Panagos, J. Romano, and P. Scott. Review, historical context, and clarifications of the NINDS rt-PA stroke trials exclusion criteria part 1: rapidly improving stroke symptoms. Stroke 44:2500–2505, 2013.
McNamara, T. Thrombolysis of peripheral arterial and graft occlusions: improved results using high-dose urokinase. Am. J. Roentgenol. 144:769–775, 1985.
Mocco, J., O. O. Zaidat, R. Von Kummer, A. J. Yoo, R. Gupta, D. Lopes, D. Frei, H. Shownkeen, R. Budzik, and Z. A. Ajani. Aspiration thrombectomy after intravenous alteplase versus intravenous alteplase alone. Stroke 47:2331–2338, 2016.
Moussaddy, A., A. M. Demchuk, and M. D. Hill. Thrombolytic therapies for ischemic stroke: triumphs and future challenges. Neuropharmacology 134:272–279, 2018.
Movasaghi, Z., S. Rehman, and I. U. Rehman. Raman spectroscopy of biological tissues. Appl. Spectrosc. Rev. 42:493–541, 2007.
Mulder, M. J., I. G. Jansen, R.-J. B. Goldhoorn, E. Venema, V. Chalos, K. C. Compagne, B. Roozenbeek, H. F. Lingsma, W. J. Schonewille, and I. R. Van Den Wijngaard. Time to endovascular treatment and outcome in acute ischemic stroke: MR CLEAN Registry results. Circulation 138:232–240, 2018.
Nam, J., H. Jing, and D. O’Reilly. Intra-arterial thrombolysis vs. standard treatment or intravenous thrombolysis in adults with acute ischemic stroke: a systematic review and meta-analysis. Int. J. Stroke 10:13–22, 2015.
Powers, W. J., A. A. Rabinstein, T. Ackerson, O. M. Adeoye, N. C. Bambakidis, K. Becker, J. Biller, M. Brown, B. M. Demaerschalk, and B. Hoh. 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 49:e46–e110, 2018.
Preissner, S., M. Dunkel, M. F. Hoffmann, S. C. Preissner, N. Genov, W. W. Rong, R. Preissner, and K. Seeger. Drug cocktail optimization in chemotherapy of cancer. PLoS ONE 7:2012.
Premasiri, W., J. Lee, and L. Ziegler. Surface-enhanced Raman scattering of whole human blood, blood plasma, and red blood cells: cellular processes and bioanalytical sensing. J. Phys. Chem. B 116:9376–9386, 2012.
Primiani, C. T., A. C. Vicente, M. T. Brannick, A. S. Turk, J. Mocco, E. I. Levy, A. H. Siddiqui, and M. Mokin. Direct aspiration versus stent retriever thrombectomy for acute stroke: a systematic review and meta-analysis in 9127 patients. J. Stroke Cerebrovasc. Dis. 28(5):1329–1337, 2019.
Qin Z., C. H. Chon, A. K. Lam, J. C. Kwok, M. M. Yuen, and D. C. Lam. Feasibility examination of isolated zonal thrombolysis using Raman spectroscopy. In: Engineering in Medicine and Biology Society (EMBC), 2015 37th Annual International Conference of the IEEEIEEE, 2015, pp. 1353–1356.
Qin, Z., F. Ciucci, C. H. Chon, J. C. Kwok, and D. C. Lam. Model development and comparison of low hemorrhage-risk endoluminal patch thrombolytic treatment for ischemic stroke. Med. Eng. Phys. 61:32–40, 2018.
Rha, J.-H., and J. L. Saver. The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke 38:967–973, 2007.
Riedel, C. H., P. Zimmermann, U. Jensen-Kondering, R. Stingele, G. Deuschl, and O. Jansen. The importance of size: successful recanalization by intravenous thrombolysis in acute anterior stroke depends on thrombus length. Stroke 42:1775–1777, 2011.
Robinson, T. G., X. Wang, H. Arima, P. M. Bath, L. Billot, J. P. Broderick, A. M. Demchuk, G. A. Donnan, J. S. Kim, and P. M. Lavados. Low-versus standard-dose alteplase in patients on prior antiplatelet therapy: the ENCHANTED trial (enhanced control of hypertension and thrombolysis stroke study). Stroke 48:1877–1883, 2017.
Roth, C., D. Junk, P. Papanagiotou, A. Keuler, H. Körner, M. Schumacher, and W. Reith. A comparison of 2 stroke devices: the new Aperio clot-removal device and the solitaire AB/FR. Am. J. Neuroradiol. 33:1317–1320, 2012.
Sikirzhytski, V., K. Virkler, and I. K. Lednev. Discriminant analysis of Raman spectra for body fluid identification for forensic purposes. Sensors 10:2869–2884, 2010.
Sung, S.-F., and M.-C. Tseng. Code stroke: a mismatch between number of activation and number of thrombolysis. J. Formos. Med. Assoc. 113:442–446, 2014.
Virkler, K., and I. K. Lednev. Raman spectroscopic signature of blood and its potential application to forensic body fluid identification. Anal. Bioanal. Chem. 396:525–534, 2010.
Wahlgren, N., N. Ahmed, A. Dávalos, G. A. Ford, M. Grond, W. Hacke, M. G. Hennerici, M. Kaste, S. Kuelkens, and V. Larrue. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. The Lancet 369:275–282, 2007.
Wardlaw, J., E. Berge, G. del Zoppo, and T. Yamaguchi. Thrombolysis for acute ischemic stroke. Stroke 35:2914–2915, 2004.
Wenger, K., F. Nagl, M. Wagner, and J. Berkefeld. Improvement of stent retriever design and efficacy of mechanical thrombectomy in a flow model. Cardiovasc. Intervent. Radiol. 36:192–197, 2013.
Yuan, Z., B. Wang, F. Li, J. Wang, J. Zhi, E. Luo, Z. Liu, and G. Zhao. Intravenous thrombolysis guided by a telemedicine consultation system for acute ischaemic stroke patients in China: the protocol of a multicentre historically controlled study. BMJ Open 5:2015.
Zaidat, O. O., A. C. Castonguay, R. G. Nogueira, D. C. Haussen, J. D. English, S. R. Satti, J. Chen, H. Farid, C. Borders, and E. Veznedaroglu. TREVO stent-retriever mechanical thrombectomy for acute ischemic stroke secondary to large vessel occlusion registry. J. Neurointerv. Surg. 10:516–524, 2018.
Zarrinkoob, L., K. Ambarki, A. Wåhlin, R. Birgander, A. Eklund, and J. Malm. Blood flow distribution in cerebral arteries. J. Cereb. Blood Flow Metab. 35:648–654, 2015.
Acknowledgments
We would like to thank the Kwong Wah Hospital for providing clinical support, and the Materials Characterization and Preparation Facility (MCPF) for providing technical support. This research was supported in part by a donation from Mr. Louis NG [Grant Number: PD-NHK17EG01].
Conflict of interest
There is a filed US provisional patent application (US 62172044) in this paper related to Zhen Qin, Chi Hang Chon, John Ching Kwong Kwok, and David C C Lam. Peter Yat Ming Woo declares that he has no conflicts of interest.
Ethical Standards
No human studies or animal studies were carried out by the authors for this article.
Author information
Authors and Affiliations
Corresponding author
Additional information
Associate Editor Michael R. King oversaw the review of this article.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Qin, Z., Chon, C.H., Kwok, J.C.K. et al. Dose–Response Relationship and Threshold Drug Dosage Identification for a Novel Hybrid Mechanical-Thrombolytic System with an Ultra-Low Dose Patch. Cel. Mol. Bioeng. 14, 627–637 (2021). https://doi.org/10.1007/s12195-021-00683-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12195-021-00683-y